Immune reactions to severe Covid may trigger brain problems, study finds

Research suggests immune response may be cause of delirium and brain fog in Covid patients

Severe Covid infections can cause immune reactions that damage nerve cells in the brain, causing memory problems and confusion, and potentially raising the risk of long-term health issues, research suggests.

Scientists at King’s College London found that a wayward immune response to the virus increased the death rate of neurons and had a “profound” impact on regeneration in the hippocampus region of the brain, which is crucial for learning and memory.

The findings are preliminary but suggest Covid can trigger neurological problems in patients without the virus having to infect the brain itself. The process is believed to underpin delirium in Covid patients, but may also contribute to brain fog and other problems experienced by people with long Covid.

“These neurological symptoms are very concerning for patients and their families, and the hope is that our research can help identify which treatments would be most appropriate to lessen or prevent these symptoms,” said Carmine Pariante, a professor of biological psychiatry at KCL’s Institute of Psychiatry, and senior author on the study.

The researchers analysed blood from 36 Covid patients admitted to Guy’s and St Thomas’ NHS Foundation Trust in London in the first wave of the pandemic. They found that levels of a protein called IL-6, which immune cells release as a rallying call for other immune cells, were more than 15 times higher than normal in infected individuals.

But an even more dramatic rise in IL-6 was found in Covid patients with delirium – a state of extreme confusion that can leave people not knowing who, or where, they are. In these patients, IL-6 was six times higher than in other Covid patients. Nearly a third of Covid patients admitted to hospital experience delirium, rising to two-thirds in severe cases.

The scientists then investigated how high levels of IL-6 might affect neurons in the hippocampus by exposing lab-grown nerve cells to the patients’ blood. They found that blood from patients with delirium increased the normal death rate of neurons and reduced the generation of new brain cells. The damage caused is thought to drive delirium.

The harmful effects were traced back to a cascade of events where IL-6 triggers the release of two related immune proteins, called IL-12 and IL-13. Dr Alessandra Borsini, the study’s first author, said the impact of the proteins on generating new brain cells was “profound”.

However, blocking the proteins protected brain cells from damage, the scientists report in Molecular Psychiatry. The work suggests drugs known as Janus kinase inhibitors, which are already used to calm dangerous immune reactions to Covid, might combat delirium and its knock-on effects.

Older people are particularly vulnerable to delirium after a range of infections and operations. The state of confusion leads to a substantial rise in the risk of dementia.

“We believe these proteins are responsible for the delirium symptoms in acute Covid patients, and in general in long Covid patients experiencing neurological symptoms,” Borsini said. Measuring the levels of the immune proteins in patients could help personalise their treatment, she added.

Dr Thomas Jackson, a geriatrician who studies delirium and inflammation at the University of Birmingham, said: “What they’ve been able to show is that increased inflammation has a direct effect on brain cells which we know are linked to delirium and memory problems. The reduction in repair mechanisms and regeneration might begin to explain why people with delirium can have longer term cognitive problems.”

He said the same immune reaction may contribute to the “brain fog” some Covid patients report, which can persist for months after infection. But confirmation will need to come from further work, he said, such as the Covid-CNS study, which is investigating 800 UK patients who had neurological or neuropsychiatric complications from Covid.


Ian Sample Science editor

The GuardianTramp

Related Content

Article image
Covid study finds millions have long-term smell or taste problems
Researchers say about 5% of infected adults may develop long-lasting changes to sense of smell or taste

Andrew Gregory Health editor

27, Jul, 2022 @10:30 PM

Article image
Mixing Covid vaccines offers strong immune protection – study
Oxford researchers say having AstraZeneca then Pfizer jabs is almost as potent as two shots of Pfizer

Ian Sample and Natalie Grover

28, Jun, 2021 @5:38 PM

Article image
First Covid wave raised UK adult risk of death by 40%, study finds
Level increased regardless of health but virus ‘picks on’ those already at risk of illness or death

Ian Sample and Nicola Davis

06, Jan, 2022 @7:00 PM

Article image
UK doing more than most to help poor get Covid vaccine, study finds
Campaign scoring countries for global access efforts calls for more British transparency

Sarah Boseley Health editor

30, Sep, 2020 @2:00 PM

Article image
UK study on mixing Covid vaccines between jabs to be expanded
Researchers to examine whether mixing vaccines may give longer-lasting immunity against virus

Sarah Marsh

14, Apr, 2021 @6:55 AM

Article image
Study shows Oxford Covid vaccine has less protection against South African variant
Researchers say vaccines’ focus must shift to protecting people from hospitalisation and death

Sarah Boseley and Jessica Murray

07, Feb, 2021 @1:07 PM

Article image
Covid-19 virus does not infect human brain cells, study suggests
Exclusive: study raises hopes that Covid-related damage to sense of smell may be more superficial than previously feared

Laura Spinney

03, Nov, 2021 @4:40 PM

Article image
Covid has caused 28m years of life to be lost, study finds
Oxford researchers arrive at virus’s toll in 31 countries by looking at deaths and age they occurred

Andrew Gregory Health editor

03, Nov, 2021 @10:30 PM

Article image
People testing negative for Covid-19 despite exposure may have ‘immune memory’
Study says some individuals clear virus rapidly due to a strong immune response from existing T-cells, meaning tests record negative result

Hannah Devlin Science correspondent

10, Nov, 2021 @4:45 PM

Article image
Covid-19 outbreaks up to 20 times more likely in large care homes, study finds
Exclusive: likelihood of UK homes being infected triples with every additional 20 beds

Robert Booth Social affairs correspondent

14, Jul, 2020 @5:00 PM